首页> 外文期刊>Cancer letters >Suppression of the notch signaling pathway by gamma-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation.
【24h】

Suppression of the notch signaling pathway by gamma-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation.

机译:γ分泌酶抑制剂GSI对Notch信号通路的抑制作用抑制了人鼻咽癌细胞的增殖。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Notch signaling has been suggested to be required for many human cancers. However, the role of Notch signaling in human nasopharyngeal carcinoma cells (NPC) remains unknown. Here, we report that Notch-1, Notch-2, Notch-3 and Notch-4 are all detected in NPC cells. Notch inhibitor, GSI, suppresses the levels of Notch-1, Notch-2 and Notch-4, but not Notch-3. In addition, GSI inhibits NPC cell proliferation by inducing the cell cycle arrest and apoptosis. Furthermore, GSI inhibits the AKT and MEK signaling, without affecting P38 and JNK1/2. Thus, NPC cells may up-regulate Notch signaling to maintain cell proliferation and targeting the Notch signaling pathway may offer a potential alternative strategy for the treatment of NPC.
机译:已经提出,Notch信号传导是许多人类癌症所必需的。但是,Notch信号在人类鼻咽癌细胞(NPC)中的作用仍然未知。在这里,我们报告Notch-1,Notch-2,Notch-3和Notch-4都在NPC细胞中被检测到。 Notch抑制剂GSI抑制Notch-1,Notch-2和Notch-4的水平,但不抑制Notch-3的水平。此外,GSI通过诱导细胞周期停滞和凋亡来抑制NPC细胞增殖。此外,GSI抑制AKT和MEK信号传导,而不影响P38和JNK1 / 2。因此,NPC细胞可以上调Notch信号传导以维持细胞增殖,并且靶向Notch信号传导途径可以为NPC的治疗提供潜在的替代策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号